Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis
- 23 October 2009
- journal article
- other
- Published by SAGE Publications in Lupus
- Vol. 18 (14) , 1276-1280
Abstract
Several studies have investigated the potential of various autoantibody tests in the diagnosis of systemic lupus erythematosus (SLE). Many lupus patients initially present with glomerulonephritis. In that clinical situation the main differential diagnosis are other forms of glomerulonephritis. In this study the diagnostic value of nine test kits for autoantibody against ANA, dsDNA, circulating immune complexes, C1q, nucleosomes, histones and Sm as well as C3 and C4 levels was evaluated in 39 patients with biopsy-proven lupus nephritis in comparison to 43 patients suffering from other forms of glomerulonephritis. The most useful test was an anti-nucleosome antibody enzyme-linked immunosorbent assay (ELISA) with a sensitivity of 90% and a specificity of 88%. All tests for anti-dsDNA antibodies (Crithidia luciliae Anti-dsDNA, BINDAZYME Anti-dsDNA, FARRZYME high avidity Anti-dsDNA) were of moderate sensitivity and very good specificity. Decreasing the cut-off for the conventional anti-dsDNA ELISA (BINDAZYME) considerably increased its sensitivity (87%) without loss of specificity (90%). Tests for anti-C1q and immune complexes performed worse than the antidsDNA tests. As anti-histone and Sm antibodies are present only in a minority of lupus nephritis patients they are of limited value in diagnosing the disease. In conclusion, testing for anti-nucleosome antibodies and the conventional anti-dsDNA ELISA with lower cut-off provide the best diagnostic aids for differentiation of lupus nephritis from other forms of glomerulonephritis. Lupus (2009) 18, 1276—1280.Keywords
This publication has 23 references indexed in Scilit:
- Lupus NephritisThe American Journal of Pathology, 2008
- A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisoloneAnnals of the Rheumatic Diseases, 2007
- High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritisNephrology Dialysis Transplantation, 2006
- Role of anti-DNA antibodies in the pathogenesis of lupus nephritisAutoimmunity Reviews, 2006
- C1q complement component and -antibodies reflect SLE activity and kidney involvementClinical Rheumatology, 2005
- Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.Journal of Clinical Investigation, 1994
- Systemic Lupus ErythematosusMedicine, 1985
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Anti‐dsdna and complement profiles as prognostic guides in systemic lupus erythematosusArthritis & Rheumatism, 1979
- IMMUNOLOGY OF DNA. III. CRITHIDIA LUCILIAE, A SIMPLE SUBSTRATE FOR THE DETERMINATION OF ANTI‐dsDNA WITH THE IMMUNOFLUORESCENCE TECHNIQUE*Annals of the New York Academy of Sciences, 1975